Compare Oscar Health Inc (OSCR) vs Snap On Incorporated (SNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Snap On Incorporated — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while Snap On Incorporated trades at $360.37 (market cap $18.56B). The key difference: Snap On Incorporated is the larger of the two by market cap, and Snap On Incorporated pays a 2.72% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Snap On Incorporated for 37 Days on average.
| OSCR | SNA | |
|---|---|---|
Market Cap | $10.22B | $18.56B |
Volume | 4,123,394 | 401,326 |
Sector | Health | Industrials |
52-Week High | $33.81 | $419.31 |
52-Week Low | $10.85 | $327.33 |
Typical Hold Time | 15 Days | 37 Days |
Enterprise Value | $6.57B | $18.20B |
Dividend Yield | — | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
Snap-On Incorporated (SNA) trades at $360.37, up 0.13% on the day, with a bearish technical outlook but strong fundamentals. The stock shows robust profitability with a 19.6% net income margin and 17.58% ROE, supported by consistent earnings beats in recent quarters. Analyst consensus is bullish with a $449 price target, though technical indicators signal selling pressure near key resistance at $361.
SNA presents a compelling investment case driven by solid earnings growth and expanding margins, but faces near-term technical headwinds and valuation risks. The stock's premium P/E of 18.31 may limit upside if growth moderates, while institutional activity shows mixed positioning. Investors should weigh strong cash flow against competitive pressures in the tools sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →
